Related Experiment Video
Updated: Feb 10, 2026

Palatable Western-style Cafeteria Diet as a Reliable Method for Modeling Diet-induced Obesity in Rodents
Published on: November 1, 2019
High fat diet induced obesity is mitigated in Cyp3a-null female mice
Ramiya Kumar1, Elizabeth J Litoff1, W Tyler Boswell1
1Biological Sciences, Clemson University, Clemson, SC 29634, United States.
Abstract:
Recent studies indicate a role for the constitutive androstane receptor (CAR), pregnane X-receptor (PXR), and hepatic xenobiotic detoxifying CYPs in fatty liver disease or obesity. Therefore, we examined whether Cyp3a-null mice show increased obesity and fatty liver disease following 8-weeks of exposure to a 60% high-fat diet (HFD). Surprisingly, HFD-fed Cyp3a-null females fed a HFD gained 50% less weight than wild-type (WT; B6) females fed a HFD. In contrast, Cyp3a-null males gained more weight than WT males, primarily during the first few weeks of HFD-treatment. Cyp3a-null females also recovered faster than WT females from a glucose tolerance test; males showed no difference in glucose tolerance between the groups. Serum concentrations of the anti-obesity hormone, adiponectin are 60% higher and β-hydroxybutyrate levels are nearly 50% lower in Cyp3a-null females than WT females, in agreement with reduced weight gain, faster glucose response, and reduced ketogenesis. In contrast, Cyp3a-null males have higher liver triglyceride concentrations and lipidomic analysis indicates an increase in phosphatidylinositol, phosphatidylserine and sphingomyelin. None of these changes were observed in females. Last, Pxr, Cyp2b, and IL-6 expression increased in Cyp3a-null females following HFD-treatment. Cyp2b and Fatp1 increased, while Pxr, Cpt1a, Srebp1 and Fasn decreased in Cyp3a-null males following a HFD, indicating compensatory biochemical responses in male (and to a lesser extent) female mice fed a HFD. In conclusion, lack of Cyp3a has a positive effect on acclimation to a HFD in females as it improves weight gain, glucose response and ketosis.
Insights
Mice lacking Cyp3a show sex-specific responses to high-fat diets (HFD). Cyp3a-null females gain less weight and improve glucose tolerance, while males exhibit increased weight gain and altered liver lipids on an HFD.
Area of Science:
- Metabolism and Endocrinology
- Pharmacology and Toxicology
- Genetics and Molecular Biology
Background:
- Obesity and fatty liver disease are linked to xenobiotic-metabolizing enzymes like constitutive androstane receptor (CAR), pregnane X-receptor (PXR), and cytochrome P450s (CYPs).
- The specific role of Cyp3a, a major drug-metabolizing enzyme, in metabolic diseases remains unclear.
Purpose of the Study:
- To investigate the impact of Cyp3a deficiency on obesity and fatty liver disease development in mice fed a high-fat diet (HFD).
Main Methods:
- Cyp3a-null mice and wild-type (WT) littermates were fed a 60% HFD for 8 weeks.
- Body weight, glucose tolerance, serum adiponectin and β-hydroxybutyrate levels, liver triglyceride content, and gene expression were analyzed.
Main Results:
- Cyp3a-null females exhibited reduced weight gain (50% less than WT), improved glucose tolerance, higher adiponectin, and lower β-hydroxybutyrate levels.
- Cyp3a-null males showed increased weight gain, elevated liver triglycerides, and altered lipid profiles (phosphatidylinositol, phosphatidylserine, sphingomyelin).
- Gene expression analysis revealed compensatory changes in PXR, Cyp2b, and IL-6 in females, and Cyp2b, Fatp1, Pxr, Cpt1a, Srebp1, and Fasn in males.
Conclusions:
- Cyp3a deficiency confers protection against HFD-induced metabolic dysfunction in female mice, improving weight gain, glucose homeostasis, and ketosis.
- In contrast, Cyp3a deficiency exacerbates certain metabolic alterations in male mice fed an HFD, suggesting sex-specific roles of Cyp3a in metabolic regulation.
Related Concept Videos
Obesity
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of...
External Female Genitals
Disorders of the Female Reproductive System
Drug Dosing: Obese Patients
Fats as Energy Storage Molecules

